Study of MAX-40279 in Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)
NCT04187495
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
AML
Interventions
DRUG:
MAX-40279-01
Sponsor
Maxinovel Pty., Ltd.